• ICPerMed
  • Activities
  • Services
  • Internal

    • PROPHET Survey on Personalised Prevention

    26 January 2024 - To bridge the gap between the slower adoption of personalised prevention strategies compared to other approaches to personalised medicine, ICPerMed family member PROPHET invites stakeholders in personalised medicine to participate in a survey on the perceived barriers, challenges and enablers to the adoption of personalised prevention strategies in the EU and beyond.

    Every year, 900,000 people in the European Union die prematurely from preventable disease risk factors. The key to reversing this trend lies in a transformative shift from treating established diseases to a 'person-centred' approach focused on disease prevention and early diagnosis. Recent scientific breakthroughs have revealed novel biomarkers, along with clinical and lifestyle data, that enable tailored preventive measures to improve individual health and prevent disease.

    Access the survey here

    The survey will take approximately 15 minutes to complete. If you are unable to complete it immediately, you can save your progress and return later. Your answers will play a key role in shaping a Strategic Research and Innovation Agenda (SRIA) for Personalised Prevention.

    PROPHET (PeRsOnalised Prevention roadmap for the future HEalThcare) will develop a Strategic Research and Innovation Agenda (SRIA) for Personalised Prevention to support the implementation of innovative, sustainable and effective personalised programmes for the prevention of common chronic diseases. Technological advances in biomedicine (including omics data and digital tools) enable risk stratification at the individual level. PROPHET will focus on stakeholder engagement and the SRIA co-creation process. The overall objective of PROPHET - the youngest member of the ICPerMed Family - is to co-create with stakeholders a personalised prevention roadmap for future healthcare to support the definition and implementation of innovative, sustainable and high quality personalised strategies that are effective in the prevention of chronic diseases.